Balanced news tone
News Sentiment
PRVA sentiment intelligence
Privia Health Group Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
83/100 classification confidence.
directly relevant articles
high-authority source matches
+0.5% over one week, +17.3% over four weeks, trend active, and materially above fair value.
Price to book forward of Privia Health Group, Inc. – NASDAQ:PRVA
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
PRVA (NASDAQ) Form 144: 17,196 shares linked to option exercise filed 06/26/2026
A Form 144 filing by Privia Health Group, Inc. (PRVA) indicates a proposed sale of 17,196 shares on June 26, 2026, linked to a stock option exercise and facilitated by Fidelity Brokerage Services. The filing also details prior dispositions by David Mountcastle in April and May 20
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 Jun 2026 20:40
- Source
- Stock Titan
Privia Health Group, Inc. Actuals & Estimates (NASDAQ:PRVA)
This article provides an overview of Privia Health Group, Inc. (NASDAQ: PRVA) stock, including its current price, performance, and analyst forecasts. It details financial actuals and estimates, frequently asked questions about the company's financials, and advice on how to invest
- Tone
- Positive 61/100
- Event
- Analyst action
- Published
- 26 Jun 2026 19:40
- Source
- TradingView
Privia Health Group Inc (PRVA) Technical Analysis: Support, Resistance, Indicators & Moving Averages
This article provides a technical analysis of Privia Health Group Inc (PRVA), detailing its current price momentum score as 9.47 and ranking it 31 out of 76 in its industry. It identifies a trading range between $22.13 (support) and $27.36 (resistance), suggesting suitability for
- Tone
- Positive 65/100
- Event
- Market update
- Published
- 24 Jun 2026 03:39
- Source
- TradingKey
VSee Health says sale refocuses telehealth business, cuts costs
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 22 Jun 2026 07:00
- Source
- Stock Titan
Privia Health Group (PRVA) Stock Could Be 24.7% Undervalued After Strong Growth
Privia Health Group (PRVA) has reported significant revenue and net profit growth, leading to increased investor attention. While some valuation models suggest the stock is undervalued by up to 24.7%, its high P/E ratio compared to the industry and peers indicates potential valua
- Tone
- Positive 65/100
- Event
- Earnings
- Published
- 22 Jun 2026 04:09
- Source
- Sahm
Privia Health Group Stock - Long-term model and volatility under review
This article examines Privia Health Group (PRVA) stock, focusing on its long-term business model and risk profile, given elevated valuation metrics and recent share price volatility. Despite no fresh corporate news, the company's physician enablement model, which aggregates indep
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 20 Jun 2026 21:10
- Source
- AD HOC NEWS
Privia's CEO Just Sold 121,000 Shares for $2.7 Million
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Jun 2026 07:00
- Source
- The Motley Fool
What Privia Health Group (PRVA)'s New Jersey Neurology Anchor Deal Means For Shareholders
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 06 Jun 2026 07:00
- Source
- simplywall.st
How The Privia Health Group (PRVA) Narrative Is Shifting With Mixed Targets And New Deals
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 Jun 2026 07:00
- Source
- Market source
Q1 Rundown: Privia Health (NASDAQ:PRVA) Vs Other Healthcare Technology for Providers Stocks
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Jun 2026 07:00
- Source
- StockStory
BrightSpring Health Services (BTSG) Stock Analysis: Exploring Growth Amidst Strong Revenue Surge
- Tone
- Positive 95/100
- Event
- Earnings
- Published
- 01 Jun 2026 07:00
- Source
- DirectorsTalk Interviews
Is Privia Health Group (PRVA) a "Smart Money" Bet After Rubicon Founders' Massive Stake Increase
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 31 May 2026 08:14
- Source
- Kavout | AI
Is Privia Health Stock a Buy After Hedge Fund Rubicon Founders Added Over 175,000 Shares to Its Position?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 30 May 2026 07:00
- Source
- The Motley Fool
New Jersey neurology care to expand as Privia joins 25-clinician group
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 27 May 2026 07:00
- Source
- Stock Titan
Privia Health Group CEO & Director Parth Mehrotra Sells 47% Of Holding
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 May 2026 07:00
- Source
- simplywall.st
Privia Health Group's (NASDAQ:PRVA) Earnings May Just Be The Starting Point
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 May 2026 07:00
- Source
- simplywall.st
Privia Health Group Q1 Earnings Call Highlights
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 08 May 2026 07:00
- Source
- TradingView
Privia now expects up to 1.625M covered lives in 2026
- Tone
- Neutral 50/100
- Event
- Guidance
- Published
- 07 May 2026 07:00
- Source
- Stock Titan
Privia Health Group Inc. (NASDAQ:PRVA): High Growth Momentum Setup with Accelerating Earnings
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 28 Apr 2026 07:00
- Source
- ChartMill
Privia Health will post Q1 results before market open on May 7
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 08 Apr 2026 07:00
- Source
- Stock Titan
How to listen to Health Catalyst’s March 12 results call
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 02 Mar 2026 08:00
- Source
- Stock Titan
Why Privia Health (PRVA) Shares Are Plunging Today
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 27 Jan 2026 08:00
- Source
- StockStory
Privia Health Announces Q2 2025 Earnings Call: Key Details for August 7 Pre-Market Release
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 10 Jul 2025 07:00
- Source
- Stock Titan
Privia Health (PRVA) Research Report
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 May 2025 12:05
- Source
- StockStory
VSee Health (VSEE) Stock Price, News & Analysis
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Apr 2025 18:07
- Source
- Stock Titan
Health Catalyst (HCAT) Stock Price, News & Analysis
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Apr 2025 17:33
- Source
- Stock Titan
Privia Health Group (PRVA) Stock Price, News & Analysis
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Apr 2025 17:25
- Source
- Stock Titan
VSee Health (VSEE) Stock News & Updates
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 27 Jun 2024 12:22
- Source
- Stock Titan
Health Catalyst (HCAT) Stock News & Updates
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 Aug 2020 16:09
- Source
- Stock Titan